Renew is the newest player to join the worldwide External Counterpulsation Therapy (ECP) market. Renew is immediately recognized in the industry as they had acquired the ECP technology from Applied Cardiac Systems (ACS). Renew is an ambitious group with goals to accomplish big things with ECP therapy both inside and outside of cardiology. In addition to ECP, Renew offers other innovative medical technologies from their U.S operations in Farmington Hills, Michigan.
Renew has a unique advantage in their recent entry into the External Counterpulsation Therapy market space. Renew is a company known for having renowned ECP technology as well as a company with great financial resources. To many experts in the industry, Renew presents an opportunity for real growth as they have the potential to expand the medical applications for ECP Therapy. As most of us agree, the mechanical delivery of oxygenated blood flow from ECP Therapy has enormous potential to be a viable & cost effective solution for a variety of medical conditions. The industry is hopeful that Renew will leverage their strength to expand this wonderful treatment to patients & clinicians worldwide.
Renew ECP Technology
When it comes to ECP technology, Renew made a good move with the acquisition of the ACS ECP technology. The NCP series is known for having a simple user interface, superior reporting capabilities and a long track record of reliability. The NCP-5 from Renew has a distinct clinical advantage in their ability to automatically report vital elements through the patented automatic ECP treatment report. The NCP series software has set the industry standard for ECP as it records, reports and trends ECP treatment data minute by minute.
Further, Renew has re-engineered this product in the smallest, lightest and most versatile platform ever seen in the U.S market. The portable configuration of the NCP-5 weighs less than 200 lbs and runs on a standard 110v power outlet. The NCP-5 can be used with their optional treatment platform where the air hoses can integrate from any side of the bed.
Renew has officially hit the streets with their newest model NCP-5 ECP system available in the U.S and worldwide. There is limited information available about the pricing structure compared to other available ECP & EECP Systems.
Legal & Safety Notice
Since Renew has recently acquired the ECP technology from ACS, there is little public information related to their manufacturing & safety processes. As for NCP series from ACS, there is no public notice for safety by the FDA or other safety or regulatory institutions.
